πŸ‡ΊπŸ‡Έ FDA
Patent

US 10844064

sGC stimulators

granted A61PA61P15/00A61P29/00

Quick answer

US patent 10844064 (sGC stimulators) held by Cyclerion Therapeutics, Inc. expires Mon Nov 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Cyclerion Therapeutics, Inc.
Grant date
Tue Nov 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61P, A61P15/00, A61P29/00, A61P9/10